The next era of Greater Boston’s biotech boom
PharmaVoice
NOVEMBER 22, 2022
How Boston became the biotech capital of the U.S., and is now preparing for the next era of life sciences growth.
Tue.Nov 22, 2022
317 
How HTA-based price controls could worsen health outcomes and health disparities
PhRMA
NOVEMBER 22, 2022
Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important decisions about patient access to health care based on their determination of the value of new tests and treatments.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
How bacteria-enabled technology for wounds could also help cancer patients
PharmaVoice
NOVEMBER 22, 2022
Evelina Vågesjö, co-founder and CEO of the immunotherapy company Ilya Pharma, is working on a new modality to speed wound healing.
CPESN Shares Payer Success Stories
Drug Topics
NOVEMBER 22, 2022
CPESN payers and their success stories.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Putting Delaware patients first: Protecting Patient Assistance Programs
PhRMA
NOVEMBER 22, 2022
Patients with chronic health conditions in Delaware are seeing a new wave of relief thanks to Governor John Carney, members of the Delaware legislature and more than 40 patient groups. The recently passed SB267 will make it easier for vulnerable patients to be able to afford their brand medications.
Forms of Cardiovascular Disease Tied to Blinding Eye Disease
Drug Topics
NOVEMBER 22, 2022
Mount Sinai study is the first to identify that heart attack, stroke and heart failure are linked to a specific type of age-related macular degeneration.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Examining Treatment Options for Rosacea and Acne
Drug Topics
NOVEMBER 22, 2022
Addressing the 2 inflammatory conditions requires careful consideration of the therapies to use.
STAT+: FDA approves a gene therapy for the inherited bleeding disorder hemophilia B
STAT
NOVEMBER 22, 2022
The Food and Drug Administration on Tuesday approved the first gene therapy to treat people with hemophilia B, an inherited bleeding disorder. The one-time treatment, called Hemgenix, was developed by the Dutch biotech company UniQure and will be marketed by CSL Behring, an Australian pharmaceutical company.
Advocacy groups press FTC to probe GPOs' role in supply chain shortages
Fierce Healthcare
NOVEMBER 22, 2022
Advocacy groups press FTC to probe GPOs' role in supply chain shortages. rking. Tue, 11/22/2022 - 16:21.
Why doesn’t the U.S. have at-home flu tests?
STAT
NOVEMBER 22, 2022
Flu season is underway. RSV is putting record numbers of children in hospitals. And health professionals are gearing up for another Covid winter. With so many potential viruses in play, it would be helpful if Americans had a way to distinguish between different ailments at home. And when it comes to the flu in particular, at-home testing could help telehealth doctors decide when it makes sense to prescribe treatments like Paxlovid and Tamiflu, which need to be administered within a specific time
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
How a Large Health System Brought All Facilities Into Compliance With Updates to USP Chapters , Before Enforcement Date
Pharmacy Times
NOVEMBER 22, 2022
Melanie Galvin, PharmD, BCSCP, explains how Northwell Health implemented changes to bring the health system up-to-date with the revisions to USP chapters and.
Using UHPLC-MS/MS for trace detection of ?-lactam antibiotics
European Pharmaceutical Review
NOVEMBER 22, 2022
A paper, published in Molecules , has developed validated the use of ultra-performance liquid chromatography with triple quadrupole mass spectrometry, or UHPLC-MS/MS, for identification and detection of the ?-lactams cephapirin and ceftiofur in cleaning solutions of the production reactors. Trace detection of ?-lactam antibiotics in cleaning rinse solutions and manufacturing aids in pharmaceutical facilities is crucial and regulated.
Analysis Results Show Reductions in HPV-Related Diseases After Using Merck’s Gardasil
Pharmacy Times
NOVEMBER 22, 2022
Data from an updated systematic literature review show positive outcomes for both cervical and non-cervical disease in men and women.
Swing’s digital therapy for fibromyalgia hits the right beat
pharmaphorum
NOVEMBER 22, 2022
Patients with fibromyalgia – a common condition causing chronic pain, fatigue, poor sleep, and cognitive dysfunction – could get relief from a digital therapeutic (DTx) based on cognitive behavioural therapy, according to a clinical trial. The Stanza DTx – developed by Swing Therapeutics and delivered via smartphone – has been put through its paces in a prospective single-arm clinical trial called REACT-FM, presented at a recent American College of Rheumatology (ACR) congress.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
FDA Accepts BLA for Genmab’s Epcoritamab to Treat Relapsed/Refractory LBCL
Pharmacy Times
NOVEMBER 22, 2022
Agency’s action date is May 21, 2023, for the first subcutaneous bispecific antibody approved for the treatment of large B-cell lymphoma.
MetroHealth System board ousts CEO after investigation reveals $1.9M in unapproved performance bonuses
Fierce Healthcare
NOVEMBER 22, 2022
MetroHealth System board ousts CEO after investigation reveals $1.9M in unapproved performance bonuses. dmuoio. Tue, 11/22/2022 - 11:29.
Pharmacist Publishes Children’s Book About Getting Your Flu Shot
Pharmacy Times
NOVEMBER 22, 2022
Our Best Shot (OBS) is a new children’s book explaining why we should get an annual flu shot and it is not something to fear…and adults may even benefit, said the author.
Clinical trials authorised for 3D-printed ulcerative colitis drug
European Pharmaceutical Review
NOVEMBER 22, 2022
Triastek, Inc. a China-based pharma company has announced it has received clearance for its Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to initiate clinical studies of T21, a 3D-printed medicine that can target specific segments in the colon to more safely deliver oral ulcerative colitis (UC) drugs. T21 is Triastek’s third FDA IND clearance for a 3D-printed medicine.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
5 Genomic Subgroups Show Promise in Helping Predict Clinical Outcomes for CLL
Pharmacy Times
NOVEMBER 22, 2022
Investigators believe the findings can refine predictions, after independent evaluation, by identifying different modes of genetic alteration.
Today’s Seniors: Independent and Active
Fierce Healthcare
NOVEMBER 22, 2022
Today’s Seniors: Independent and Active. ncapone. Tue, 11/22/2022 - 16:28.
Umoja and IASO partner to develop therapies for haematological malignancies
Pharmaceutical Technology
NOVEMBER 22, 2022
Umoja Biopharma has signed a research agreement with IASO Biotherapeutics (IASO Bio) to develop off-the-shelf therapies for haematological malignancies. Under the alliance, the companies will assess the induced cytotoxic innate lymphocytes (iCIL) platform of Umoja with chimeric antigen receptors (CARs) of IASO to develop the next generation of widely accessible, easily available cell therapies.
State attorneys general call on Apple to beef up privacy protections for reproductive health information
Fierce Healthcare
NOVEMBER 22, 2022
State attorneys general call on Apple to beef up privacy protections for reproductive health information. hlandi. Tue, 11/22/2022 - 12:32.
Store brands shine as consumer wallets tighten
Drug Store News
NOVEMBER 22, 2022
Retailers’ private label product sales are growing as consumers seek affordable health-and-wellness solutions.
Senate bill seeks to improve Medicare handbook amid spike in marketing complaints
Fierce Healthcare
NOVEMBER 22, 2022
Senate bill seeks to improve Medicare handbook amid spike in marketing complaints. rking. Tue, 11/22/2022 - 11:09.
GSK will pull Blenrep from US market after failed trial
pharmaphorum
NOVEMBER 22, 2022
GSK confirmed this morning that the disappointing readout from the DREAMM-3 trial of multiple myeloma therapy Blenrep reported earlier this month means that it will take the drug off the US market. The company said it has started the processing for withdrawing the marketing authorisation for Blenrep (belantamab mafodotin) at the request of the FDA. Some patients will be able to continue to receive the drug via a compassionate use programme.
How Clinical Trials Can Thrive in the Digital Era
PharmExec
NOVEMBER 22, 2022
The Digital Medicine Society (DiMe) CEO Jennifer Goldsack and Takeda’s Head of Digital Health Sciences, Data Sciences Institute Shoibal Datta describe the current landscape of digitized clinical trials and the decisions needed to fully utilize their potential.
Eugia Pharma Specialities gets FDA OK for generic AmBisome Liposome for Injection
Drug Store News
NOVEMBER 22, 2022
Amphotericin B liposome for injection, 50 mg /vial is a partnership product from TTY Biopharm.
A simple screening question could help millions of women prevent cardiovascular disease. Why aren’t we using it?
STAT
NOVEMBER 22, 2022
Early one afternoon in 2000, Monique Shields, just a few weeks shy of her 30th birthday, left her busy day as an executive assistant at Starbucks’ corporate headquarters to go to her routine prenatal checkup. Feeling healthy, as she had throughout her 34 weeks of pregnancy, she stopped by her home outside of Seattle, changed into her flip-flops, and drove the five minutes to the appointment at her obstetrician’s office.
Merck to acquire Imago for $1.35 billion
European Pharmaceutical Review
NOVEMBER 22, 2022
Merck has announced it will acquire biopharma Imago BioSciences, Inc for around $1.35 billion in total equity value, to facilitate development of Imago’s lead candidate bomedemstat (IMG-7289), an investigational oral lysine-specific demethylase 1 (LSD1) inhibitor for myeloproliferative neoplasms (MPNs). ”Robert M. Davis, President and Chief Executive Officer at Merck declared, “This acquisition of Imago strengthens our presence in the growing field of haematology.”.
U.K. analysis shows one dose of monkeypox vaccine yields strong protection
STAT
NOVEMBER 22, 2022
An analysis released Tuesday by U.K. health officials indicates that even one dose of the monkeypox vaccine provides strong protection against the virus. Researchers at the U.K. Health Security Agency estimated that one dose of the vaccine was 78% effective at protecting against infection 14 or more days after vaccination.
Japan grants emergency regulatory approval for Shionogi’s Covid-19 drug
Pharmaceutical Technology
NOVEMBER 22, 2022
The Ministry of Health, Labour and Welfare (MHLW) in Japan has granted emergency regulatory approval for Shionogi ’s new anti-SARS-CoV-2 drug, Xocova (ensitrelvir fumaric acid, S-217622), for Covid-19. This approval under the emergency regulatory approval system is granted under the Article 14-2-2 of the Pharmaceuticals and Medical Devices Act, the company noted.
One-third of U.S. labs have stopped using race-based equations to diagnose kidney disease
STAT
NOVEMBER 22, 2022
Even as a child, La’Tonzia Adams was interested in diagnosing disease. One day, when she noticed a bump on her chest, she decided to look up “chicken pox” in the Webster’s dictionary at her grandmother’s house to figure out if her symptoms matched the illness. “I remember I scratched it, and it was watery,” said Adams.
Nonprofit health systems' Q3 earnings: Baylor Scott & White, Sutter Health's operations stand tall among the pack
Fierce Healthcare
NOVEMBER 22, 2022
Nonprofit health systems' Q3 earnings: Baylor Scott & White, Sutter Health's operations stand tall among the pack. dmuoio. Tue, 11/22/2022 - 22:37.
Let's personalize your content